Benzinga's Top Downgrades


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Analysts at Keefe Bruyette & Woods downgraded Bank of America Corp

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

(NYSE: BAC) from Outperform to Market Perform. The target price for Bank of America has been lowered from $17 to $16. Bank of America shares dropped 0.14 percent to $13.86 in pre-market trading.Analysts at DA Davidson downgraded Infoblox Inc (NYSE: BLOX) from Neutral to Underperform. Infoblox shares declined 2.99 percent to close at $18.47 on Friday.Goldman Sachs downgraded Weibo Corp (ADR) (NASDAQ: WB) from Buy to Neutral. The target price for Weibo has been raised from $20 to $22. Weibo shares fell 2.83 percent to $22.64 in pre-market trading.Berenberg downgraded

FREE REPORT: How To Learn Options Trading Fast

In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, ​a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.


Deutsche Bank AG (USA) (NYSE: DB) from Hold to Sell. Deutsche Bank shares slipped 0.15 percent to $16.36 in pre-market trading.Analysts at Compass Point downgraded Patriot National Inc (NYSE: PN) from Buy to Neutral. The target price for Patriot National has been lowered from $13 to $10. Patriot National shares fell 0.38 percent to close at $7.80 on Friday.Morgan Stanley downgraded Bitauto Hldg Ltd (ADR) (NYSE: BITA) from Equal-weight to Underweight. The target price for Bitauto has been lowered from $28 to $20. Bitauto shares declined 1.17 percent to $21.19 in pre-market trading.Leerink Swann downgraded Epirus Biopharmaceuticals Inc (NASDAQ: EPRS) from Outperform to Market Perform. EPIRUS Biopharmaceuticals shares rose 0.04 percent to close at $0.78 on Friday.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Posted In: DowngradesAnalyst RatingsTop Downgrades